Real‐world outcomes of adjuvant therapies in stage <scp>III</scp> / <scp>IV</scp> melanoma: Insights from the French <scp>RIC</scp> ‐ <scp>MEL</scp> cohort

M. Vuillemey, G. Quereux, P. Celérier et al.|Journal of the European Academy of Dermatology and Venereology|2025

Cited by 0